These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6146808)

  • 21. A unique epitope exposed in native complement component C9 and hidden in the terminal SC5b-9 complex enables selective detection and quantification of non-activated C9.
    Mollnes TE; Tschopp J
    J Immunol Methods; 1987 Jun; 100(1-2):215-21. PubMed ID: 2439601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid immunoturbidimetric assay of albumin and immunoglobulin G in serum and cerebrospinal fluid with an automatic discrete analyser.
    Kamp HH; Luderer TK; Muller HJ; Sopjes-Kruk A
    Clin Chim Acta; 1981 Aug; 114(2-3):195-205. PubMed ID: 6793271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oligoclonal bands in multiple sclerosis].
    Coret F; Enguídanos MJ; Benedito J; Burguera JA; Vílchez JJ; Fernández S
    Neurologia; 1987; 2(4):158-61. PubMed ID: 3274122
    [No Abstract]   [Full Text] [Related]  

  • 24. A longitudinal study on antibodies to measles and rubella viruses in patients with multiple sclerosis. A preliminary report.
    Reunanen M; Arstila P; Hakkarainen H; Nikoskelainen J; Salmi A; Panelius M
    Acta Neurol Scand; 1976 Oct; 54(4):366-70. PubMed ID: 973556
    [No Abstract]   [Full Text] [Related]  

  • 25. Soluble immune complexes in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.
    Glikmann G; Svehag SE; Hansen E; Hansen O; Husby S; Nielsen H; Farrell C
    Acta Neurol Scand; 1980 Jun; 61(6):333-43. PubMed ID: 6998248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Complement 3 level in the cerebrospinal fluid in multiple sclerosis].
    Wajgt A
    Neurol Neurochir Pol; 1980; 14(3):275-82. PubMed ID: 7412984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C9 in multiple sclerosis.
    Patterson V
    Lancet; 1984 Aug; 2(8400):458. PubMed ID: 6147518
    [No Abstract]   [Full Text] [Related]  

  • 28. An improved formula for the judgement of intrathecally produced IgG in the presence of blood brain barrier damage.
    Ohman S; Forsberg P; Nelson N; Vrethem M
    Clin Chim Acta; 1989 May; 181(3):265-72. PubMed ID: 2758680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiple sclerosis--studies of the correlations between selected parameters of immune response and the clinical course of the disease].
    Losy J; Michałowska-Wender G; Tokarz E; Wender M
    Neurol Neurochir Pol; 1992; 26(2):164-71. PubMed ID: 1528374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligoclonal bands and the IgG index in multiple sclerosis: uses and limitations.
    Giles PD; Heath JP; Wroe SJ
    Ann Clin Biochem; 1989 Jul; 26 ( Pt 4)():1317-23. PubMed ID: 2764482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive viral immunology of multiple sclerosis. I. Clinical, epidemiological, and CSF studies.
    Johnson KP; Likosky WH; Nelson BJ; Fein G
    Arch Neurol; 1980 Sep; 37(9):537-41. PubMed ID: 7417053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroimmunological findings in Guillain Barré syndrome, multiple sclerosis, and idiopathic polyneuropathies.
    Dorta-Contreras A; Silva-Somoza R
    Mol Chem Neuropathol; 1996; 28(1-3):279-84. PubMed ID: 8871970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of immunoglobulin within the central nervous system in multiple sclerosis and other neurological diseases. Detection by analysis of CSF/serum IgG ratio.
    Sun T; Fleming JO; Beresford HR; Lien YY
    Am J Clin Pathol; 1981 Oct; 76(4):458-61. PubMed ID: 7293969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A haemolytic assay for the measurement of C9 in human serum and cerebrospinal fluid.
    Asghar SS; Siem H; van der Helm HJ
    Clin Chim Acta; 1987 Jun; 165(2-3):387-90. PubMed ID: 3652460
    [No Abstract]   [Full Text] [Related]  

  • 35. Cerebrospinal fluid immunoglobulin quotients, kappa/lambda ratios, and viral antibody titres in neurological disease.
    Roberts-Thomson PJ; Esiri MM; Young AC; Maclennan IC
    J Clin Pathol; 1976 Dec; 29(12):1105-15. PubMed ID: 188871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases.
    Rawes JA; Calabrese VP; Khan OA; DeVries GH
    Mult Scler; 1997 Dec; 3(6):363-9. PubMed ID: 9493635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Cobas 8000® for the quantification of albumin and IgG in serum and cerebrospinal fluid.
    Puissant-Lubrano B
    Clin Biochem; 2018 Jun; 56():105-108. PubMed ID: 29654728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analytical performances of SPAPLUS® turbidimeter for the quantification of albumin and IgG in serum and cerebrospinal fluid.
    Benard C; Chauzeix J; Blancher A; Puissant-Lubrano B
    Clin Biochem; 2016 Jul; 49(10-11):828-31. PubMed ID: 27048976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid and blood assays of diagnostic usefulness in multiple sclerosis.
    Johnson KP
    Neurology; 1980 Jul; 30(7 Pt 2):106-9. PubMed ID: 6156430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
    Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
    Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.